Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education
Full head-to-head: PlexusDx vs MEDVi →
Full head-to-head: PlexusDx vs Remedy Meds →
This is an independent editorial review. PlexusDx has no commercial relationship with Medvi or Remedy Meds, and no affiliate links or compensation are involved.
Medvi and Remedy Meds both dispense compounded GLP-1 medication, but they package and price it differently, and one of them shows almost nothing until you finish an intake quiz. This review lays out each medication line-up and what is actually published on price, so the comparison rests on documented figures rather than assumptions. Both are among dozens of programs live as of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
What Medvi puts on the table
Medvi operates as telehealth plus compounded pharmacy. Its main program dispenses compounded semaglutide and tirzepatide (weekly injection) plus a dissolvable GLP-1 tablet through licensed compounding pathways, and it separately offers brand-name Wegovy and Zepbound at a $99 membership plus medication cost. On the compounded side, Medvi leads with an ongoing monthly rate — $299/month for compounded semaglutide and $399/month for compounded tirzepatide, as captured July 2026 — with no membership fee. See Medvi's official website for current details.
What Remedy Meds puts on the table
Remedy Meds also operates as telehealth plus compounded pharmacy, but it publishes no public prices — a rate appears only after you complete its intake quiz. The one tier captured is its microdose at $189/month (July 2026). Current program and medication details are posted at Remedy Meds's official website.
Reading the two price structures
The contrast is transparency as much as amount. Medvi posts standing monthly rates; Remedy Meds gates pricing behind a quiz and surfaces only a microdose tier publicly. For an apples-to-apples microdose comparison, the PlexusDx Microdose GLP-1 Protocol runs $129/mo flat. Program details change, so verify current pricing directly on each brand's own site before any purchase decision.
The evidence behind the compounds
Whatever the price structure, the molecules are the same. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide act on appetite, satiety, and gastric emptying, with a record built on STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). The compound, not the pricing page, drives the biology.
The genetic variable behind every dose
Neither program's intake reads your genetics. Variants in FTO, GLP1R (the receptor every GLP-1 compound binds), MC4R, and TCF7L2 describe the appetite and glucose-handling baseline behind any dose. They are pathway-level markers, not predictors of response to a specific compound, but they add context a price tier cannot. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across those genes.
The PlexusDx microdose comparison
Beyond the microdose protocol, PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — each paired with the genetic read that neither Medvi nor Remedy Meds includes.
Not affiliated: PlexusDx has no commercial ties to Medvi or Remedy Meds and was not compensated for this review.
Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.
Disclaimer: This article is educational. PlexusDx is not affiliated with Medvi or Remedy Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Frequently Asked Questions
What medications does Medvi dispense?
Medvi's compounded program dispenses compounded semaglutide and tirzepatide as weekly injections plus a dissolvable GLP-1 tablet, and it separately offers brand-name Wegovy and Zepbound at a membership plus medication cost. Doses and options change over time, so confirm the current line-up on Medvi's own site.
Why does Remedy Meds hide its pricing?
Remedy Meds publishes no public prices; a rate appears only after you complete its intake quiz, with a microdose tier at $189/month captured in July 2026. Quiz-gated pricing is common in this category, but it means you cannot compare full costs without starting intake.
How do the microdose options compare?
Remedy Meds's captured microdose tier runs $189/month, while the PlexusDx Microdose GLP-1 Protocol runs $129/mo flat. Because Medvi leads with standard monthly compounded rates rather than a microdose tier, a like-for-like microdose comparison sits between Remedy Meds and PlexusDx. Verify current figures on each site.
Does the genetic test change which medication I need?
No. The Precision Peptide Genetic Test does not predict response to any compound or recommend a dose. It maps pathway-level variants in FTO and MC4R, and TCF7L2 to describe your baseline biology, giving you context to discuss with a provider alongside the medication and pricing details.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Hers vs Medvi: Subscription Telehealth and Compounded Care
Hers vs Medvi: Subscription Telehealth and Compounded Care